Grey Wolf Animal Health Company Description
Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada.
The company operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit.
It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics.
It provides pharmaceuticals, which includes sedaject, ataject, and thyro-tabs canine drugs; and wound care products, including medical tubes, viscose net dressings, alginate dressing, absorbent foam dressing, elastic bandages, and silicone perforated tapes, as well as medical pet shirt protective wear that comprise pet shirt, pets boot, head cover, and leg sleeves.
The company also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, which includes Microsilver, Composure Pro, Vertiflex, hide and treat, L-Lysine Pro, Renal Essentials Pro, and Hepaticlear Pro, as well as Entero Aid +Gi and Fibre Boost +Gi health products.
Grey Wolf Animal Health Corp. is headquartered in Toronto, Canada.
Country | Canada |
Industry | Personal Services |
Sector | Consumer Discretionary |
CEO | Angela Cechetto |
Contact Details
Address: Bay Adelaide – West Tower Toronto, Ontario M5H 2R2 Canada | |
Website | greywolfah.com |
Stock Details
Ticker Symbol | WOLF |
Exchange | TSX Venture Exchange |
Fiscal Year | January - December |
Reporting Currency | CAD |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Angela Cechetto | Chief Executive Officer and Secretary |
Dr. Ian Sandler | Founder, Chief Veterinary Medical Officer and Director |
Brandon Mair-Wren | Vice President of Operations |